Vestal Point Capital »

Nurix Therapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $10M 500k 20.87

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Nurix Therapeutics

BlackRock
Redmile Group
Deep Track Capital
Baker Bros. Advisors
Vanguard Group
T. Rowe Price Associates
State Street Corporation
ARK Investment Management
T. Rowe Price Investment Management
Soleus Capital Management
Morgan Stanley
Geode Capital Management
Driehaus Capital Management
Candriam Luxembourg S.C.A.
Citadel Advisors

View all funds holding Nurix Therapeutics